SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000921895-18-001770
Filing Date
2018-05-21
Accepted
2018-05-21 17:30:28
Documents
7

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 2 TO THE SCHEDULE 13D sc13da210042007_05212018.htm SC 13D/A 198541
2 BROADFIN AGREEMENT ex991to13da210042007_052118.htm EX-99.1 59094
3 AMENDMENT TO AGREEMENT ex992to13da210042007_052118.htm EX-99.2 7773
4 FORM OF DIRECTOR RETIREMENT AGREEMENT ex993to13da210042007_052118.htm EX-99.2 33156
5 SECURITIES PURCHASE AGREEMENT ex994to13da210042007_052118.htm EX-99.3 183858
6 REGISTRATION RIGHTS AGREEMENT ex995to13da210042007_052118.htm EX-99.4 79923
7 JOINT FILING AGREEMENT ex996to13da210042007_052118.htm EX-99.6 6637
  Complete submission text file 0000921895-18-001770.txt   570586
Mailing Address 4131 PARKLAKE AVENUE SUITE 225 RALEIGH NC 27612
Business Address 4131 PARKLAKE AVENUE SUITE 225 RALEIGH NC 27612 919 582 9050
BIODELIVERY SCIENCES INTERNATIONAL INC (Subject) CIK: 0001103021 (see all company filings)

IRS No.: 352089858 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-57907 | Film No.: 18850743
SIC: 2834 Pharmaceutical Preparations

Mailing Address 300 PARK AVENUE, 25TH FLOOR NEW YORK NY 10022
Business Address 300 PARK AVENUE, 25TH FLOOR NEW YORK NY 10022 212-808-2463
Broadfin Capital, LLC (Filed by) CIK: 0001511901 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A